Melcam 15 mg tablet is a medicine made by Square Pharmaceuticals PLC. Melcam is used for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
There are 13 brands of Meloxicam listed in Bangladesh. 3 of them have a lower unit price than Melcam. The lowest listed price is Melcam 7.5 mg Tablet at ৳ 4.03 per unit.
What is Melcam 15 mg Tablet?
The tablet Melcam contains Meloxicam and is made by Square Pharmaceuticals PLC. Meloxicam is strongly bound to plasma proteins and is extensively metabolised in the body. Because Meloxicam is an NSAID, it can affect the stomach and gut, and it can interact with other medicines, so treatment should be supervised by a doctor. Ask your doctor or pharmacist if you are unsure about it.
Uses of Melcam
Melcam is used for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. In these joint conditions, Meloxicam works as a non-steroidal anti-inflammatory drug, reducing inflammation and pain. It does not reverse joint damage, and it is not a substitute for other treatment your doctor may advise. Ask your doctor whether it is right for your condition.
How to use Melcam
Swallow the tablet with water. Melcam is taken by mouth. Swallow the tablet as advised. Do not change the dose or stop early without asking your doctor. Do not stop or change the medicine without medical advice.
Side effects of Melcam
People allergic to aspirin or other NSAIDs may develop an asthma attack. Some people get skin rash or urticaria, or swelling of the lower limbs. Common problems include nausea, vomiting, abdominal pain, indigestion, constipation or diarrhoea. Tell your doctor promptly about stomach pain, black stools, unusual bleeding, swelling or breathing problems. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Older people need closer supervision. Melcam is not suitable for everyone. It should be avoided by people allergic to Meloxicam or to aspirin and other NSAIDs, and by people with active or recent peptic ulcer, gastrointestinal bleeding, severe liver failure, severe kidney failure not on dialysis, or bleeding disorders. Tell your doctor if you have heart disease or its risk factors, fluid retention or heart failure, kidney or liver problems, or a history of stomach bleeding or ulcers.
Frequently asked questions
What does Melcam treat?
Melcam is used for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. In these joint conditions, Meloxicam works as a non-steroidal anti-inflammatory drug, reducing inflammation and pain.
How do I use Melcam correctly?
Swallow the tablet with water. Melcam is taken by mouth.
What are the side effects of Melcam?
People allergic to aspirin or other NSAIDs may develop an asthma attack. Some people get skin rash or urticaria, or swelling of the lower limbs.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The bioavailability of Meloxicam following oral administration is 89% on the average. With the doses of 7.5 mg & 15 mg plasma concentrations are proportional to dose: 0.4 to 1.0 mg/litre for 7.5 mg & 0.8 to 2.0 mg/litre for 15 mg, on an average. Meloxicam is very strongly bound to plasma proteins, essentially albumin (99%). Meloxicam is extensively metabolised, chiefly by oxidation of the methyl redical attached to the thiazolyl ring. Elimination in unchanged form accounts for 3% of the dose. Half of the substance is eliminated in urine & the other half in the faeces. The mean elimination half life is 20 hours.
Dosage & Administration
For Adults:
Osteoarthritis: 7.5 mg/day. If necessary, in the absence of improvement, the dose may be increased to 15 mg/day.
Rheumatoid arthritis: 15 mg/day. In elderly patients the recommended dose for long term treatment is 7.5 mg/day.
Ankylosing spondylitis: 15 mg/day. In elderly patients the recommended dose is 7.5 mg/day.
Do not exceed the dose of 15 mg/day. The total daily amount should be taken as a single dose. Patients with increased risks for adverse reactions should start treatment with 7.5 mg/day. In dialysis patients with severe renal failure the dose should not exceed 7.5 mg/day
For Children: The pharmacokinetics of Meloxicam in paediatric patients under 18 years of age have not been investigated.
Interaction
Other NSAIDs, including high doses of salicylates: Administration of several NSAIDs together may increase the risk of ulcers and of gastrointestinal bleeding, via a synergistic effect.
Oral anticoagulants, heparin and ticlopidine: Increased risk of bleeding via inhibition of platelet function and damage to the gastroduodenal mucosa. Careful monitoring of the effects of anticoagulants is thus essential if it proves impossible to avoid such combined prescription.
Lithium: NSAIDs increase blood lithium levels, which may then reach toxic values.
Methotrexate: NSAIDs may accentuate the haematologic toxicity of methotrexate.
Intrauterine contraceptive devices: NSAIDs appear to decrease the efficacy of intrauterine contraceptive devices.
Contraindications
Meloxicam is contraindicated to patients hypersensitive to this drug. Meloxicam should not be given to patients who have developed signs of asthma, nasal polyps, angioneurotic oedema or urticaria following the administration of aspirin or NSAIDs. Meloxicam is contraindicated to patients with active peptic ulcer during the last six months or a history of recurrent peptic ulcer disease, severe hepatic failure, non-dialysed severe renal failure, gastrointestinal bleeding, cerebrovascular bleeding or other bleeding disorders.
Side Effects
Nausea, vomiting, abdominal pain, dyspepsia, constipation or diarrhoea may occur. Ulcers or gastrointestinal bleeding may rarely occur. Skin rash, or urticaria may occur in some individuals. Oedema of the lower limbs may occur during treatment. Onset of an asthma attack has been reported in certain individuals allergic to aspirin or to other NSAIDs. Headache, vertigo or drowsiness may occur.
Pregnancy & Lactation
It is advisable to avoid the administration of Meloxicam during pregnancy. It is unknown whether Meloxicam passes into mother’s milk. Meloxicam should not be given to nursing mothers.
Precautions & Warnings
Patient with known CV disease or risk factors for CV disease, fluid retention or heart failure, history of GI bleeding or ulceration. Hepatic and renal impairment. Elderly. Pregnancy and lactation.
Storage Conditions
Store Meloxicam tablet in a cool & dry place and away from light. Store Meloxicam suppository below 25˚C protected from light and moisture.
Alternative brands of Meloxicam
Other brands with the same generic name, cheapest first.